Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity - Schedule of All Outstanding Options Activity (Details)

v3.23.3
Stockholders' Equity - Schedule of All Outstanding Options Activity (Details) - USD ($)
$ / shares in Units, $ in Thousands
9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Jan. 01, 2022
Options Outstanding      
Beginning Balance (in shares) 110,000 117,500  
Cancelled/expired (in shares) (6,000) (7,500)  
Granted (in shares) 10,000    
Ending Balance (in shares) 114,000 110,000 117,500
Exercisable (in shares) 114,000    
Weighted Average Exercise Price      
Beginning Balance (in usd per share) $ 6.27 $ 7.16  
Cancelled/expired (in usd per share) 9.45 0  
Granted (in usd per share) 1.53    
Ending Balance (in usd per share) 5.68 $ 6.27 $ 7.16
Exercisable (in usd per share) $ 5.68    
Options outstanding, intrinsic value $ 0 $ 0 $ 21
Options exercisable, intrinsic value $ 0    
Weighted Average Remaining Contractual Life 6 years 4 months 24 days 6 years 6 months 7 years
Weighted Average Remaining Contractual Life, Exercisable 6 years 4 months 24 days